ACBM stock

ACRO Biomedical Co Ltd (ACBM) financials · $1.6M cap

ACRO Biomedical Co Ltd (ACBM) $1.6M cap.

Cached annual income statement
LineFY2025
Revenue$0
Cost of Revenue$0
Gross Profit$0
Operating Income-$154.0K
Net Income-$101.1K
EPS (Diluted)$0.00
Cached annual balance sheet
LineFY2025FY2024
Total Assets$14.1K$32.0K
Current Assets$14.1K$5.1K
Cash & Equivalents$0$0
Inventory$0$0
PP&E$0$0
Total Liabilities$14.1K$326.9K
Current Liabilities$401.1K$326.9K
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity-$387.0K-$295.0K
Retained Earnings-$32.8M-$32.7M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$196.3K-$36.7K
CapEx$0$0
Investing Cash Flow$0$0
Financing Cash Flow$199.9K$36.8K
Dividends Paid$0$0
Net Change in Cash$0$0
Free Cash Flow$0$0

FAQ

What is ACBM P/E and revenue?

ACRO Biomedical Co Ltd (ACBM) $1.6M cap.

What is ACBM revenue?

ACRO Biomedical Co Ltd last cached revenue is $0 (FY2025).

Is ACBM profitable?

ACRO Biomedical Co Ltd last cached net income is -$101.1K.

What are ACBM total assets?

ACRO Biomedical Co Ltd last cached total assets are $14.1K.

What is ACBM free cash flow?

ACRO Biomedical Co Ltd last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.